Correction to Sanofi Article
April 07 2020 - 4:27AM
Dow Jones News
Sanofi has finalized the restructuring related to Praluent with
Regeneron. "Sanofi Finalizes Praulent Restructuring With
Regeneron," at 0539 GMT, misstated the name of the drug in the
headline. The drug is called Praluent, not Praulent.
(END) Dow Jones Newswires
April 07, 2020 04:12 ET (08:12 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Regeneron Pharmaceuticals (NASDAQ:REGN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Regeneron Pharmaceuticals (NASDAQ:REGN)
Historical Stock Chart
From Apr 2023 to Apr 2024